We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Alzheimer's Disease May Be Triggered by Age-Specific Genes

By Biotechdaily staff writers
Posted on 26 Nov 2003
Researchers have found that an individual's likelihood to develop Alzheimer's disease is determined by different groups of genes that are related to the age at which the individual begins to experience symptoms of the disease.

Investigators at Duke University (Durham, NC, USA; www.duke.edu) employed a novel method of analysis, called "ordered subsets linkage analysis,” to perform genomic screening of 437 families in which at least two members had Alzheimer's disease. More...
This method of screening allowed them to identify genetic regions linked to Alzheimer's disease specifically in families that differed in terms of their average age at onset but without making assumptions about how those age groups should be defined.

Results published in the November 2003 issue of the American Journal of Human Genetics revealed a region on chromosome 2 linked to Alzheimer's disease in families with a minimum age at onset between 50 and 60 years. A second region, located on chromosome 15 was associated with the disorder only in families with a minimum age at onset of 80 years. A third region on chromosome 9 was found to influence late onset Alzheimer's disease in families that experienced symptoms between the ages of 60 and 75.

"By including age at onset in our analysis using this new method, we have identified genetic regions that may be associated with Alzheimer's disease that we would not have found otherwise,” explained first author Dr. William Scott, an associate research professor at Duke University.




Related Links:
Duke University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.